Mannose-binding lectin levels and major infections in a cohort of very long-term survivors after allogeneic stem cell transplantation

Haematologica

Volumn 95, Issue 8, 2010, Pages 1389-1396

  Osthoff, Michael ^a   Rovó, Alicia ^a   Stern, Martin ^a   Danner, Doris ^a   Gratwohl, Alois ^a   Tichelli, André ^a   Trendelenburg, Marten ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Life threatening infections; MBL levels; Stem cell transplantation

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETOPOSIDE; MANNOSE BINDING LECTIN; METHOTREXATE; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CANCER SURVIVOR; CHILD; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HERPES VIRUS INFECTION; HERPES ZOSTER; HIGH RISK POPULATION; HUMAN; INFECTION; INFECTION RISK; INFECTION SENSITIVITY; MALE; MYELODYSPLASTIC SYNDROME; NEUTROPHIL COUNT; NONHODGKIN LYMPHOMA; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SCHOOL CHILD; T CELL DEPLETION; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX; HUMANS; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SURVIVORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 77956049581     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.017863     Document Type: Article

References (42)

1. Bouwman LH, Roep BO, Roos A. Mannose-binding lectin: clinical implications for infection, transplantation, and autoimmunity. Hum Immunol. 2006;67(4-5):247-56.
2. Lu JH, Thiel S, Wiedemann H, Timpl R, Reid KB. Binding of the pentamer/hexamer forms of mannan-binding protein to zymosan activates the proenzyme C1r2C1s2 complex, of the classical pathway of complement, without involvement of C1q. J Immunol. 1990;144(6):2287-94.
3. Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, Turner MW. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun. 2000; 68(2):688-93.
4. Garred P, Larsen F, Seyfarth J, Fujita R, Madsen HO. Mannose-binding lectin and its genetic variants. Genes Immun. 2006; 7(2):85-94.
5. Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency--revisited. Mol Immunol. 2003;40(2-4):73-84.
6. Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequencespecific primers. J Immunol Methods. 2000; 241(1-2):33-42.
7. Eisen DP, Dean MM, Boermeester MA, Fidler KJ, Gordon AC, Kronborg G, et al. Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection. Clin Infect Dis. 2008; 47(4):510-6.
8. Herpers BL, Endeman H, de Jong BA, de Jongh BM, Grutters JC, Biesma DH, et al. Acute-phase responsiveness of mannosebinding lectin in community-acquired pneumonia is highly dependent upon MBL2 genotypes. Clin Exp Immunol. 2009; 156(3):488-94.
9. Fidler KJ, Wilson P, Davies JC, Turner MW, Peters MJ, Klein NJ. Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin. Intensive Care Med. 2004;30(7):1438-45.
10. Roos A, Garred P, Wildenberg ME, Lynch NJ, Munoz JR, Zuiverloon TC, et al. Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency. Eur J Immunol. 2004;34(9):2589-98.
11. Petersen SV, Thiel S, Jensen L, Steffensen R, Jensenius JC. An assay for the mannanbinding lectin pathway of complement activation. J Immunol Methods. 2001; 257(1-2):107-16.
12. Ytting H, Christensen IJ, Thiel S, Jensenius JC Svendsen MN, Nielsen L, et al. Biological variation in circulating levels of mannan-binding lectin (MBL) and MBLassociated serine protease-2 and the influence of age, gender and physical exercise. Scand J Immunol. 2007;66(4):458-64.
13. Thiel S, Holmskov U, Hviid L, Laursen SB, Jensenius JC. The concentration of the Ctype lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin Exp Immunol. 1992; 90(1):31-5.
14. Chaudhry SH, Chaudhry S, Jansen-Hoogendijk AM, Jol van der Zijde CM, van Tol MJ Roos A, et al. Mannose-binding lectin levels and infections in children after allogeneic hematopoietic SCT. Bone Marrow Transplant. 2010;45(2):289-93.
15. Koch A, Melbye M, Sorensen P, Homoe P, Madsen HO, Molbak K, et al. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. Jama. 2001;285(10):1316-21.
16. Cedzynski M, Szemraj J, Swierzko AS, Bak-Romaniszyn L, Banasik M, Zeman K, et al. Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system. Clin Exp Immunol. 2004;136(2):304-11.
17. de Benedetti F, Auriti C, D'Urbano LE, Ronchetti MP, Rava L, Tozzi A, et al. Low serum levels of mannose binding lectin are a risk factor for neonatal sepsis. Pediatr Res. 2007;61(3):325-8.
18. Manuel O, Pascual M, Trendelenburg M, Meylan PR. Association between mannosebinding lectin deficiency and cytomegalovirus infection after kidney transplantation. Transplantation. 2007; 83(3):359-62.
19. Worthley DL, Johnson DF, Eisen DP, Dean MM, Heatley SL, Tung JP, et al. Donor mannose-binding lectin deficiency increases the likelihood of clinically significant infection after liver transplantation. Clin Infect Dis. 2009;48(4):410-7.
20. Verschuren JJ, Roos A, Schaapherder AF, Mallat MJ, Daha MR, de Fijter JW, et al. Infectious complications after simultaneous pancreas-kidney transplantation: a role for the lectin pathway of complement activation. Transplantation. 2008;85(1):75-80.
21. Rocha V, Franco RF, Porcher R, Bittencourt H, Silva WA Jr, Latouche A, et al. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood. 2002;100(12):3908-18.
22. Mullighan CG, Heatley S, Doherty K, Szabo F, Grigg A, Hughes TP, et al. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood. 2002;99(10):3524-9.
23. Granell M, Urbano-Ispizua A, Suarez B, Rovira M, Fernandez-Aviles F, Martinez C, et al. Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation. Exp Hematol. 2006;34(10):1435-41.
24. Mullighan CG, Heatley SL, Danner S, Dean MM, Doherty K, Hahn U, et al. Mannosebinding lectin status is associated with risk of major infection following myeloablative sibling allogeneic hematopoietic stem cell transplantation. Blood. 2008;112(5):2120-8.
25. Neth OW, Bacher U, Das P, Zabelina T, Kabisch H, Kroeger N, et al. Influence of mannose-binding lectin genotypes and serostatus in Allo-SCT: analysis of 131 recipients and donors. Bone Marrow Transplant. 2010;45(1):13-9.
26. Gratwohl A, Brand R, Frassoni F, Rocha V, Niederwieser D, Reusser P, et al. Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time. Bone Marrow Transplant. 2005;36(9):757-69.
27. Socie G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med. 1999;341(1):14-21.
28. Robin M, Porcher R, De Castro Araujo R, de Latour RP, Devergie A, Rocha V, et al. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor. Biol Blood Marrow Transplant. 2007;13(11): 1304-12.
29. Bjorklund A, Aschan J, Labopin M, Remberger M, Ringden O, Winiarski J, et al. Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation. Bone Marrow Transplant. 2007;40(11):1055-62.
30. Ochs L, Shu XO, Miller J, Enright H, Wagner J, Filipovich A, et al. Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients. Blood. 1995;86(10):3979-86.
31. Baerlocher GM, Rovo A, Muller A, Matthey S, Stern M, Halter J, et al. Cellular senescence of white blood cells in very long-term survivors after allogeneic hematopoietic stem cell transplantation: the role of chronic graft-versus-host disease and female donor sex. Blood. 2009;114(1): 219-22.
32. Gordon AC, Waheed U, Hansen TK, Hitman GA, Garrard CS, Turner MW, et al. Mannose-binding lectin polymorphisms in severe sepsis: relationship to levels, incidence, and outcome. Shock. 2006;25(1):88-93.
33. Neth O, Hann I, Turner MW, Klein NJ. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet. 2001; 358(9282):614-8.
34. Gadjeva M, Takahashi K, Thiel S. Mannanbinding lectin--a soluble pattern recognition molecule. Mol Immunol. 2004;41(2-3): 113-21.
35. Fujimaki K, Maruta A, Yoshida M, Kodama F, Matsuzaki M, Fujisawa S, et al. Immune reconstitution assessed during five years after allogeneic bone marrow transplantation. Bone Marrow Transplant. 2001; 27(12):1275-81.
36. Martinez C, Urbano-Ispizua A, Rovira M, Carreras E, Rozman C, Montserrat E. Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation. Leuk Lymphoma. 2000;37(5-6): 535-42.
37. Ghods FJ, Solgi G, Amirzargar AA, Nikbin B, Ghods AJ. High frequency of clinically significant infections and cytomegalovirus disease in kidney transplant recipients with serum mannose-binding lectin deficiency. Iran J Kidney Dis. 2009;3(1): 28-33.
38. Cervera C, Lozano F, Saval N, Gimferrer I, Ibanez A, Suarez B, et al. The influence of innate immunity gene receptors polymorphismsin renal transplant infections. Transplantation. 2007;83(11):1493-500.
39. Neth O, Jack DL, Johnson M, Klein NJ, Turner MW. Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannose-binding lectin-associated serine protease after binding to Staphylococcus aureus. J Immunol. 2002;169(8):4430-6.
40. Vekemans M, Robinson J, Georgala A, Heymans C, Muanza F, Paesmans M, et al. Low mannose-binding lectin concentrationis associated with severe infection in patients with hematological cancer who are undergoing chemotherapy. Clin Infect Dis. 2007;44(12):1593-601.
41. Peterslund NA, Koch C, Jensenius JC, Thiel S. Association between deficiency of mannose- binding lectin and severe infections after chemotherapy. Lancet. 2001;358 (9282):637-8.
42. Kilpatrick DC, Stewart K, Allan EK, McLintock LA, Holyoake TL, Turner ML. Successful haemopoietic stem cell transplantation does not correct mannan-binding lectin deficiency. Bone Marrow Transplant. 2005;35(2):179-81.